293 related articles for article (PubMed ID: 17486504)
1. Sickle cell disease: a multigenic perspective of a single gene disorder.
Kutlar A
Hemoglobin; 2007; 31(2):209-24. PubMed ID: 17486504
[TBL] [Abstract][Full Text] [Related]
2. Role of epistatic (modifier) genes in the modulation of the phenotypic diversity of sickle cell anemia.
Nagel RL; Steinberg MH
Pediatr Pathol Mol Med; 2001; 20(2):123-36. PubMed ID: 12673837
[TBL] [Abstract][Full Text] [Related]
3. The influence of uridine diphosphate glucuronosyl transferase 1A promoter polymorphisms, beta-globin gene haplotype, co-inherited alpha-thalassemia trait and Hb F on steady-state serum bilirubin levels in sickle cell anemia.
Adekile A; Kutlar F; McKie K; Addington A; Elam D; Holley L; Clair B; Kutlar A
Eur J Haematol; 2005 Aug; 75(2):150-5. PubMed ID: 16004608
[TBL] [Abstract][Full Text] [Related]
4. Molecular biology of hemoglobin: its application to sickle cell anemia and thalassemia.
Kan YW
Schweiz Med Wochenschr Suppl; 1991; 43():51-4. PubMed ID: 1726857
[TBL] [Abstract][Full Text] [Related]
5. Sickle cell disease: a multigenic perspective of a single-gene disorder.
Kutlar A
Med Princ Pract; 2005; 14 Suppl 1():15-9. PubMed ID: 16103709
[TBL] [Abstract][Full Text] [Related]
6. Raised Hb F levels in sickle cell disease are caused by a determinant linked to the beta globin gene cluster.
Kulozik AE; Thein SL; Kar BC; Wainscoat JS; Serjeant GR; Weatherall DJ
Prog Clin Biol Res; 1987; 251():427-39. PubMed ID: 2448811
[TBL] [Abstract][Full Text] [Related]
7. [Genetic polymorphism of drepanocytosis].
Pagnier J; Wajcman H; Baudin V; Labie D
Ann Genet; 1985; 28(1):5-12. PubMed ID: 2409889
[TBL] [Abstract][Full Text] [Related]
8. Hemoglobin switching and its clinical implications.
Blau CA; Stamatoyannopoulos G
Curr Opin Hematol; 1994 Mar; 1(2):136-42. PubMed ID: 9371272
[TBL] [Abstract][Full Text] [Related]
9. Limitations of Hb F as a phenotypic modifier in sickle cell disease: study of Kuwaiti Arab patients.
Adekile AD
Hemoglobin; 2011; 35(5-6):607-17. PubMed ID: 21999156
[TBL] [Abstract][Full Text] [Related]
10. Overview of pathophysiology and rationale for treatment of sickle cell anemia.
Rodgers GP
Semin Hematol; 1997 Jul; 34(3 Suppl 3):2-7. PubMed ID: 9317195
[TBL] [Abstract][Full Text] [Related]
11. The developmental genetics of human hemoglobin.
Weatherall DJ; Wood WG; Jones RW; Clegg JB
Prog Clin Biol Res; 1985; 191():3-25. PubMed ID: 2413475
[TBL] [Abstract][Full Text] [Related]
12. [Genetic modifiers of homozygous sickle cell disease].
Hartmann K; Kulozik AE
Klin Padiatr; 2006; 218(3):170-3. PubMed ID: 16688674
[TBL] [Abstract][Full Text] [Related]
13. Molecular analysis of the high-hemoglobin-F phenotype in Saudi Arabian sickle cell anemia.
Miller BA; Olivieri N; Salameh M; Ahmed M; Antognetti G; Huisman TH; Nathan DG; Orkin SH
N Engl J Med; 1987 Jan; 316(5):244-50. PubMed ID: 2432426
[TBL] [Abstract][Full Text] [Related]
14. Modifier genes and sickle cell anemia.
Steinberg MH; Adewoye AH
Curr Opin Hematol; 2006 May; 13(3):131-6. PubMed ID: 16567954
[TBL] [Abstract][Full Text] [Related]
15. Understanding mechanisms of gamma-globin gene regulation to develop strategies for pharmacological fetal hemoglobin induction.
Pace BS; Zein S
Dev Dyn; 2006 Jul; 235(7):1727-37. PubMed ID: 16607652
[TBL] [Abstract][Full Text] [Related]
16. Genomic polymorphisms in sickle cell disease: implications for clinical diversity and treatment.
Fertrin KY; Costa FF
Expert Rev Hematol; 2010 Aug; 3(4):443-58. PubMed ID: 21083035
[TBL] [Abstract][Full Text] [Related]
17. Sickle cell disease due to compound heterozygosity for Hb S and a novel 7.7-kb beta-globin gene deletion.
Andersson BA; Wering ME; Luo HY; Basran RK; Steinberg MH; Smith HP; Chui DH
Eur J Haematol; 2007 Jan; 78(1):82-5. PubMed ID: 17038017
[TBL] [Abstract][Full Text] [Related]
18. Defining stroke risks in sickle cell anemia.
Meschia JF; Pankratz VS
Nat Genet; 2005 Apr; 37(4):340-1. PubMed ID: 15800645
[No Abstract] [Full Text] [Related]
19. Predicting clinical severity in sickle cell anaemia.
Steinberg MH
Br J Haematol; 2005 May; 129(4):465-81. PubMed ID: 15877729
[TBL] [Abstract][Full Text] [Related]
20. Dominant influence of gamma-globin promoter polymorphisms on fetal haemoglobin expression in sickle cell disease.
Ofori-Acquah SF; Lalloz MR; Serjeant G; Layton DM
Cell Mol Biol (Noisy-le-grand); 2004 Feb; 50(1):35-42. PubMed ID: 15040425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
